Alta Advisers’s Idexx Laboratories IDXX Stock Holding History

Alta Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-296	Closed	-$200K	–	213
2025 Q4	$200K	Sell	296 -80	-21%	-$54.5K	0.07%	198
2025 Q3	$240K	Hold	376	–	–	0.07%	219
2025 Q2	$202K	Buy	+376	New	+$180K	0.07%	243
2024 Q4	–	Sell	-300	Closed	-$152K	–	283
2024 Q3	$152K	Hold	300	–	–	0.07%	198
2024 Q2	$146K	Hold	300	–	–	0.07%	176
2024 Q1	$162K	Hold	300	–	–	0.08%	163
2023 Q4	$167K	Hold	300	–	–	0.09%	141
2023 Q3	$131K	Hold	300	–	–	0.08%	165
2023 Q2	$151K	Hold	300	–	–	0.08%	146
2023 Q1	$150K	Hold	300	–	–	0.09%	141
2022 Q4	$122K	Hold	300	–	–	0.07%	177
2022 Q3	$98K	Buy	+300	New	+$110K	0.06%	204

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alta Advisers's IDXX Position: Q1 2026 in Review

Alta Advisers sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 296 shares — an estimated $200K sold.

Alta Advisers first reported a position in IDXX in Q3 2022 and held it in 12 quarters. The position peaked at $240K in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Alta Advisers reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Alta Advisers sold 296 Idexx Laboratories shares in Q1 2026, an estimated $200K.
Alta Advisers first reported a position in Idexx Laboratories in Q3 2022 and held it in 12 quarters.
Alta Advisers's Idexx Laboratories position peaked at $240K in Q3 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Alta Advisers's 13F filing for Q1 2026, filed 7 May 2026.